Recruiting

Observational Study

Sponsor:

University of Wisconsin, Madison

Code:

NCT03023202

Conditions

Hematologic Neoplasms

Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PMMTB (Precision Medicine Molecular Tumor Board)

Study Details

Brief summary:

This study seeks to evaluate the clinical utility of the Precision Medicine Molecular Tumor Board, and to track patient outcomes.

Conditions

Hematologic Neoplasms

Solid Neoplasm

Study ID

NCT03023202

Start date

Mar 30, 2016

Status verified date

Apr, 2026

Completion date

Mar, 2029

Anticipated

Primary completion date

Mar, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Clinically suspected or histologically confirmed solid or hematological malignancy
  • Undergoing genetic testing of tumor
  • Ability to understand written informed consent document
  • Willingness to sign written informed consent document

Exclusion Criteria:

  • Pediatric patients (age<18 years) will be excluded due to a lack of expertise on the molecular tumor committee

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Arms

PMMTB

This study of the PMMTB will include all patients >= 18 with clinically suspected or histologically confirmed solid or hematological malignancy who will undergo genetic testing of their tumor.

All standard of care functions will be performed by standard procedures.

Interventions

PMMTB (Precision Medicine Molecular Tumor Board)

PMMTB is a clinical intervention, NOT a research intervention. The research component of this study is to observe the outcomes of the PMMTB.

Primary outcome measure

  • Frequency of acceptance of molecular tumor board recommendations [ Time Frame: Up to 5 years ]
  • Benefit from PMMTB recommended treatment [ Time Frame: Up to 5 years ]

Central Contacts and Locations

Central contacts

Cancer Connect

8006228922clinicaltrials@cancer.wisc.edu

Locations

University of Wisconsin Carbone Cancer Center

Recruiting

Madison, Wisconsin, United States, 53792

Contacts

Cancer Connect

800-622-8922clinicaltrials@cancer.wisc.edu

More Information

Sponsor

University of Wisconsin, Madison

Last update posted

Apr 13, 2026

Last verified

Apr, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Wisconsin, Madison on 2026-04-13.